The pharmaceutical sector has issued a strident, urgent plea to the Health Department. They are imploring officials to immediately reconsider the newly gazetted 1.4% SEP increase in the maximum Single Exit Price (SEP) for medicines in 2026. The adjustment, set at a mere 1.47%, is a significant blow to the industry. They had anticipated an increase more than double that…
Tag: Investment
-
Lilly Hits $1 Trillion Valuation with Weight-Loss Success
In a historic milestone for the pharmaceutical industry, Eli Lilly surged to a market value of $1 trillion on Friday. It became the first drugmaker to join an exclusive club previously dominated by technology heavyweights. This event marked the moment Lilly hit a $1 trillion valuation. It highlighted the company’s rapid ascent as a global powerhouse in the weight-loss sector.…
-
Adcock Ingram: A picture of resilience in a challenging market
Pharmaceutical stalwart Adcock Ingram presents a compelling case for investors seeking resilience amidst potential market turbulence. The group boasts a robust track record, with a mere 3% dip in headline earnings per share (HEPS) during the challenging Covid-impacted year of 2021. It was their worst annual performance in a decade. Since 2015, Adcock has delivered an impressive 16.2% compound annual…
-
Clicks Group: The Value Behind the Price Tag
Clicks Group is undeniably a powerhouse on the JSE. It is widely recognised as a well-managed and resilient business. However, a persistent question dogs potential investors, particularly those inclined towards scepticism: is Clicks Group simply too expensive to justify buying? While it’s true that Clicks trades at a premium compared to many other retailers, this doesn’t automatically mean it’s never…
-
Discovery reports a 34% increase in first-half earnings
Discovery has revealed a robust 34% increase in its first-half headline earnings, showcasing its strong growth trajectory. This surge is primarily attributed to the exceptional performance of its South African health insurance division and the globally recognised Vitality programme. Key Financial Highlights: Headline Earnings: Increased by 34% to R4.35 billion (£234 million) for the six months ending December, rising from…